Pietrangelo A, Panduro A, Chowdhury J R, Shafritz D A
Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461.
J Clin Invest. 1992 Jun;89(6):1755-60. doi: 10.1172/JCI115778.
A novel feedback regulatory mechanism operating on transcription of the albumin gene is described in the rat. In 1946, it was proposed that circulating colloids, including serum albumin, may affect the synthesis and/or secretion of albumin in the liver. The molecular basis for this proposed regulation has now been investigated by adding oncotically active macromolecules to the circulation of normal or genetically albumin-deficient Nagase analbuminemic rats (NAR) and analyzing the hepatic expression of genes, including albumin after 24 h. The transcription rate of the albumin gene was higher in NAR than in normal rats and was dramatically reduced by raising serum albumin to 1.6 g/dl. Intravenous infusion of albumin into normal rats also decreased transcriptional activity of the albumin gene by 50-60%, and this decrease correlated with changes in serum colloid osmotic pressure after albumin infusion. Inhibition of albumin gene transcription was also observed upon intravenous infusion of other protein or nonprotein macromolecules, such as gamma-globulin and dextran. This down-regulation appears to control the steady-state level of albumin mRNA in the liver. Aside from a concomitant decrease in apo E gene transcription after albumin or macromolecule infusion, there was no change in the transcription rate of other genes, including those exhibiting liver-preferred or -specific expression (e.g., tyrosine amino-transferase, cytochrome P-450, alpha 1-antitrypsin, apolipoproteins A-I and B, and transferrin) or general cellular expression (e.g., alpha-tubulin, pro alpha 2 collagen, and beta-actin). Feedback regulation of albumin gene expression by serum colloids may serve as a specific homeostatic mechanism to maintain the steady-state level of total protein in the circulation.
在大鼠中描述了一种作用于白蛋白基因转录的新型反馈调节机制。1946年有人提出,包括血清白蛋白在内的循环胶体可能会影响肝脏中白蛋白的合成和/或分泌。现在通过向正常或基因缺陷的长谷川无白蛋白血症大鼠(NAR)的循环系统中添加具有渗透活性的大分子,并分析24小时后包括白蛋白在内的基因的肝脏表达情况,对这种假定调节的分子基础进行了研究。白蛋白基因的转录率在NAR中高于正常大鼠,当血清白蛋白升高到1.6g/dl时,转录率显著降低。向正常大鼠静脉输注白蛋白也使白蛋白基因的转录活性降低了50-60%,这种降低与输注白蛋白后血清胶体渗透压的变化相关。静脉输注其他蛋白质或非蛋白质大分子,如γ-球蛋白和右旋糖酐时,也观察到白蛋白基因转录受到抑制。这种下调似乎控制了肝脏中白蛋白mRNA的稳态水平。除了输注白蛋白或大分子后载脂蛋白E基因转录随之降低外,其他基因的转录率没有变化,包括那些表现出肝脏优先或特异性表达的基因(如酪氨酸转氨酶、细胞色素P-450、α1-抗胰蛋白酶、载脂蛋白A-I和B以及转铁蛋白)或一般细胞表达的基因(如α-微管蛋白、原α2胶原蛋白和β-肌动蛋白)。血清胶体对白蛋白基因表达的反馈调节可能是一种维持循环中总蛋白稳态水平的特定稳态机制。